Related Experiment Video
Updated: Aug 8, 2026
Multiplexed Fluorometric ImmunoAssay Testing Methodology and Troubleshooting
Published on: December 12, 2011
Adaptation of commercial immunoassays to analysis of complex biological substances
Michael J Lacy1, Rong Wang, Valerie Brookshire
1Corixa Corporation, Hamilton, MT 59840, USA.
Insights
Accurate quantification of Intracellular Adhesion Molecule I (ICAM-1) and Melanoma Inhibitory Activity (MIA) in cell lysates was achieved using immunoassays. Optimal sample dilutions were determined to mitigate matrix effects for reliable biomarker measurement.
Area of Science:
- Biochemistry
- Molecular Biology
- Immunology
Background:
- Immunoassays are crucial for quantifying biomarkers in biological samples.
- Complex matrices like cell lysates can interfere with assay accuracy.
- Melanoma research requires precise measurement of specific proteins.
Purpose of the Study:
- To evaluate the accuracy of ICAM-1 and MIA immunoassays in melanoma cell lysates.
- To determine optimal sample preparation and dilution for reliable quantitation.
- To assess potential matrix effects impacting assay performance.
Main Methods:
- Melanoma cell lysates were prepared using detergents, with Triton X-100 optimizing antigen solubility.
- Immunoassay accuracy was assessed by determining appropriate sample dilution ranges.
- Spiking experiments were conducted to identify and quantify matrix effects.
- Bicinchoninic acid assay was used for protein quantitation.
Main Results:
- Optimal dilutions for accurate ICAM-1 and MIA quantitation were identified (50-fold for ICAM-1, 5-fold for MIA).
- Matrix effects were evaluated at these optimal dilutions.
- The bicinchoninic acid protein assay's accuracy was also assessed.
- Assays demonstrated good precision, linearity, specificity, and robustness.
Conclusions:
- Validated methods allow for accurate quantification of ICAM-1 and MIA in melanoma cell lysates.
- Understanding and controlling matrix effects are essential for reliable immunoassay results.
- These findings support the use of these immunoassays for biomarker studies in complex biological samples.
Abstract:
An Intracellular Adhesion Molecule I (ICAM-1) immunoassay from R and D Systems, and a Melanoma Inhibitory Activity (MIA) immunoassay from Roche Diagnostics were tested for accurate quantitation within complex biological substances such as cell lysates. Prior to assay, lysates of melanoma cells were treated with detergents to obtain soluble antigens. Maximum ICAM-1 and maximum MIA were detected after treatment using 0.8% Triton X-100. Two key aspects of assay accuracy were: 1) determining the dilutions of test sample that provided accurate quantitation (sample range), and 2) performing spiking experiments at these dilutions to determine absence or presence of a "matrix" effect due to biological complexity of the sample. A high degree of accuracy was found by diluting this particular cellular extract 50-fold prior to ICAM-1 assay, or only 5-fold prior to MIA assay. In addition, the bicinchoninic acid protein assay was analyzed to test the accuracy of protein quantitation of cellular lysates. Precision, limits of detection, and quantitation, robustness, linearity, and specificity also were tested for the immunoassays.
